Jump to content

Trimedoxime bromide

From Wikipedia, the free encyclopedia

This is the current revision of this page, as edited by FK1954 (talk | contribs) at 16:29, 30 September 2023 (+ asoxime). The present address (URL) is a permanent link to this version.

(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)
Trimedoxime bromide
Clinical data
Routes of
administration
Intramuscular injection
ATC code
  • None
Legal status
Legal status
  • Experimental; in military use
Pharmacokinetic data
Elimination half-life2 hours (mean)
Identifiers
  • 1,1-propane-1,3-diylbis{4-[(E)-(hydroxyimino)methyl]pyridinium} dibromide
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
ECHA InfoCard100.000.276 Edit this at Wikidata
Chemical and physical data
FormulaC15H18Br2N4O2
Molar mass446.143 g·mol−1

Trimedoxime bromide (INN), also known as dipyroxime or TMB-4, is an oxime used in the treatment of organophosphate poisoning[1] It is chemically related to asoxime, pralidoxime, and obidoxime.[2]

References

[edit]
  1. ^ Dhuguru J, Zviagin E, Skouta R (January 2022). "FDA-Approved Oximes and Their Significance in Medicinal Chemistry". Pharmaceuticals. 15 (1). Basel, Switzerland: 66. doi:10.3390/ph15010066. PMC 8779982. PMID 35056123.
  2. ^ Gupta R, Parmar M (2022). "Pralidoxime". StatPearls. Treasure Island (FL): StatPearls Publishing. PMID 32644334.